Home › Neuroendocrine Tumors › Iowa › Cedar Rapids
Neuroendocrine Tumors clinical trials in Cedar Rapids, IA
7 studies for Neuroendocrine Tumors are looking for participants at sites in and around Cedar Rapids (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
RecruitingPhase 3
- University of Iowa Health Care, Iowa City · 25 mi away
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
RecruitingPhase 1
- Research Facility, Iowa City · 25 mi away
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi away
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
RecruitingPhase 1/2
- University of Iowa, Iowa City · 25 mi away
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
RecruitingPhase 3
- Research Facility, Iowa City · 25 mi away
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Iowa City · 25 mi away
177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry
RecruitingPhase 2
- Holden Comprehensive Cancer Center at the University of Iowa, Iowa City · 25 mi away
Neuroendocrine Tumors trials in other cities
- Washington, DC11 studies
- Philadelphia, PA11 studies
- Rochester, MN9 studies
- Salt Lake City, UT8 studies
- Houston, TX8 studies
- St. Louis, MO8 studies
- Columbus, OH8 studies
- Cleveland, OH7 studies
- New York City, NY7 studies
- Miami, FL7 studies
- Chicago, IL7 studies
- Detroit, MI7 studies
Other studies in Cedar Rapids
- Non-Small Cell Lung Cancer20 studies
- Breast Cancer17 studies
- Acute Myeloid Leukemia16 studies
- Cancer (all types)15 studies
- Multiple Myeloma15 studies
- Lung Cancer14 studies
- Colorectal Cancer13 studies
- Prostate Cancer12 studies
- Head and Neck Squamous Cell Carcinoma12 studies
- Melanoma10 studies
- Stroke10 studies
- Metastatic Cancer9 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.